Here, we report a similar signature whereby TWEAK-induced p52 activity resulted in the increased enrichment of oncogenic motifs, such as various ETS factors, KAISO and ZEB1, at ETS1 binding sites and augmented genome-wide ETS1 DNA binding, which altered the transcriptomic landscape of gliomas. Here, ZEB1 is linked to central nervous system cancer.